Consultant- Cytogenetics

About us: Revvity is an international developer and provider of end-to-end solutions designed to help scientists, researchers, and clinicians solve the world s greatest health challenges. We have deep experience in our field, having been part of Revvity s 85-year history, and are excited for our future as a dedicated life sciences & diagnostics business. Our diverse team of 11,000+ colleagues from around the globe are vital to our success and the reason we re able to push boundaries in pursuit of better human health.

Site - India

Business Unit - Diagnostic Laboratory Operations

To train/ advise cytogenetics team on the karyotype analysis and nomenclature as per ISCN 2020. Will be involved in checking the karyotype images, assessing the team s results and confirming the same in timely manner. Will be involved in reporting out Karyotype and FISH (if applicable) on daily basis as per mutual agreement. Expected to carry out all responsibilities in accordance with the organizations policies, standard operating procedures, and best practices. Always ensures compliance with all applicable laws and regulations. Other responsibilities include mentoring employees for Karyotype analysis and nomenclature; evaluate performance of junior personnel for karyotyping and nomenclature, ensure accurate clinical samples reporting and successful proficiency testing.

• Checking karyotype images and advising the results
• Checking karyotype images and confirm team s results and nomenclature
• Ensure ICSN nomenclature is followed appropriately for all cases reported out
• Trouble Shooting for wetlab as required.
• Finalizing and reporting the cases for karyotyping (as mutually agreed).
• Work timing would be based on either
  • Minimum cases per day as per mutually agreed terms
• • Minimum time of 2 to 3 hrs per day as mutually agreed
• Training the team to be competent in identification and representing the karypotype abnormalities as per ISCN 2020
• Physical presence may be needed for specific audits
• Maintain proposed TAT for tests - Karyotyping. Prioritize urgent Reports when necessary.